-Toshihiro Miyamoto Researcher Activity Profile

Research Author Detailed Information 

Toshihiro Miyamoto Publication Rate By Year

Toshihiro Miyamoto has published 9 paper(s) in 2007, 3 paper(s) in 2008, for a total of 12 research publications in total.

Toshihiro T Miyamoto Author Information

LAST NAME: miyamoto

FIRST NAME: toshihiro

INITIALS: T

AFFILIATION:

Papers

Toshihiro Miyamoto's Publication Record

1. Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. Year Published: 2007
Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
2. Collection of mobilized peripheral blood stem cells from a donor with severe iron deficient anemia. Year Published: 2007
Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan. kamezaki@pa2.so-net.ne.jp
3. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Year Published: 2007
Research Unit for Human Disease Model, Rikagaku Kenkyusho (RIKEN) Research Center for Allergy and Immunology, Yokohama, Japan.
4. Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. Year Published: 2007
Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
5. Collection of mobilized peripheral blood stem cells from a donor with severe iron deficient anemia. Year Published: 2007
Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan. kamezaki@pa2.so-net.ne.jp
6. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation. Year Published: 2007
First Department of Internal Medicine, Kyushu University, Fukuoka, Japan. anonamin@yahoo.co.jp
7. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Year Published: 2007
Research Unit for Human Disease Models, RIKEN Research Center for Allergy and Immunology, 1-7-22 Suehiro-cho Tsurumi-ku, Yokohama 230-0045, Japan. f_ishika@rcai.riken.jp
8. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Year Published: 2007
Research Unit for Human Disease Models, RIKEN Research Center for Allergy and Immunology, 1-7-22 Suehiro-cho Tsurumi-ku, Yokohama 230-0045, Japan. f_ishika@rcai.riken.jp
9. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Year Published: 2007
Research Unit for Human Disease Model, Rikagaku Kenkyusho (RIKEN) Research Center for Allergy and Immunology, Yokohama, Japan.
10. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling. Year Published: 2008
First Department of Internal Medicine, Graduate School of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; anonamin@yahoo.co.jp.
11. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling. Year Published: 2008
First Department of Internal Medicine, Graduate School of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. anonamin@yahoo.co.jp
12. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling. Year Published: 2008
First Department of Internal Medicine, Graduate School of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. anonamin@yahoo.co.jp